Hepatitis C Virus Infection in Dialysis and Clinical Nephrology

Choo Q.L. , Kuo G. , Weiner A.J. . Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–61.

Kuo G. , Choo Q.L. , Alter M.J. . An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4.

Aach R. , Stevens C. , Hollinger B. . Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 1991; 325: 1325–9.

Alter M.J. , Hadler S.C. , Judson F.N. . Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231–5.

Takahashi K. , Okamoto H. , Kishimoto S. . Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts. J Gen Virol 1992; 73: 667–72.

Hu K.Q. , Yu C.H. , Vierling J.M. . Direct detection of circulation of hepatitis C virus RNA using probed from the 5'untranslated region. J Clin Invest 1992; 89: 2040–5.

Blight K. , Trowbridge R. , Rowland R. , Gowans E. . Detection of hepatitis C virus RNA in situ hybridization. Liver 1992; 12: 286–9.

Weiner A.J. , Brauer M. , Rosenblatt J. . Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842–8.

Kato N. , Yokosuka O. , Hosoda K. , Ito Y. , Ohto M. , Omata M. . Detection of hepatitis C virus RNA in acute non-A, non-B hepatitis as an early diagnostic tool. Biochem and Biophys Res Comm 1993; 192: 800–7.

Shimizu Y.K. , Weiner A.J. , Rosenblatt J. . Early events in hepatitis C virus infection of chimpazees. Proceedings of the National Academy of Sciences of the USA 1990; 87: 6441–4.

Beach M.J. , Meeles E.L. , Mimms L.T. . Temporal relationships of hepatitis C virus RNA and antibody responses followingg experimental infection of chimpanzees. J Med Virol 1992; 36: 226–37.

Barbara J.A.J. , Garson J.A. . Polymerase chain reaction and transfusion microbiology. Vox Sang 1993; 64: 73–81.

Garson J.A. , Tedder R.S. , Briggs P. . Detection of hepatitis C viral sequences in blood donations by ‘nested’ polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419–22.

Wolff C. , Schluter K. , Prohaska W. , Kleesiek K. . Improved detection of hepatitis C virus RNA by reverse transcription and polymerase chain reaction. Eur J Clin Chem and Clin Biochem 1992; 30: 717–27.

Garson J.A. , Ring C.J.A. , Tuke P.W. . Improvement of HCV genome detection with “short” PCR products. Lancet 1991; 338: 1466–7.

Gretch D.R. , Wilson J.J. , Carithers R.L. , Dela Rosa C. , Han J.H. , Corey L. . Detection of hepatitis C virus RNA: comparison of one-stage polymerase chain reaction (PCR) with nested-set PCR. J Clin Microbiol 1993; 13: 289–91.

Okamoto H. , Okada S. , Sugiyama T. , Tanaka T. . Detection of hepatitis virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5’ noncoding region. J Exp Med 1990; 60: 215–22.

Lin H.J. , Shi N. , Mizokami M. . Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs. J Med Virol 1992; 38: 220–5.

Ravaggi A. , Primi D. , Cariani E. . Direct amplification of HCV RNA from human serum. PCR Meth Appl 1992; 1: 291–2.

Prati D. , Capelli C. , Bosoni P. . Determination of HCV RNA in the serum by the Amplicor HCV PCR kit. Vox Sang 1994; 67: 112–4.

Takehara T. , Hayashi N. , Mita E. . Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue. Hepatology 1992; 15: 387–90.

van Doom L.J. , van Belkum A.F. , Maertens G. . Hepatitis C virus antibody detection by a line immunoassay and (near) full length genomic RNA detection by a new RNA-capture polymerase chain reaction. J Med Virol 1992; 38: 298–304.

van Doorn L.J. , Kleter B. , Voermans J. . Rapid detection of hepatitis C virus RNA by direct capture from blood samples. J Med Virol 1994; 42: 22–8.

Ulrich P.P. , Romeo J.M. , Daniel L.J. . An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA. PCR Meth Appl 1993; 2: 241–9.

Zaajier H.L. , Cuypers H.T.M. , Reesink H.W. . Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722–4.

Busch M.P. , Wilber J.C. , Johnson P. , Tobler L. , Evans C.S. . Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion 1992; 32: 420–5.

Wang J.T. , Wang T.H. , Sheu J.C. , Lin S.M. , Chen D.S. . Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 1992; 30: 750–3.

Lau J.Y.N. , Davis G.L. , Kniffen J. . Significance of serum hepatitis C virus RNA levels in chronic hepatitis. Lancet 1993; 341: 1501–4.

Shindo M. , Di Bisceglie A. , Cheung L. . Decrease in serum hepatitis C viral RNA during alpha-interpheron therapy for chronic hepatitis. Ann Intern Med 1991; 115: 700–4.

Weiland O. , Zhang Y.Y. , Widell A. . Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interpheron alpha-2b treatment after relapse following initial treatment. Scan J Infect Dis 1993; 25: 25–30.

Kaneko S. , Murakami S. , Unoura M. , Kobayashi K. . Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction. J Med Virol 1992; 37: 278–82.

Hagiwara H. , Hayashi N. , Mita E. . Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993; 17: 545–50.

Urdea M.S. . Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV and HIV. Clin Chem 1993; 39: 725–6.

Simmonds P. , Holmes E.C. , Chan T.A. . Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol 1994; 74: 2391–4.

Okamoto H. , Sugiyama Y. , Okada S. . Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673–9.

Pozzato G. , Kaneko S. , Moretti M. , Crocé L.S. . Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43: 291–6.

Yoshioka K. , Kakumu S. , Wakiti T. . Detection of hepatitis C virus by polymerase chain reaction and responses to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293–9.

Takada N. , Takase S. , Enomoto N. , Takada A. , Date T. . Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol 1992; 14: 35–40.

Chemello L. , Alberti A. , Rose K. . Hepatitis C serotype and response to interferon therapy. (Letter) N Engl J Med 1994; 330: 143.

Chan S.W. , Simmonds P. , McOmish F. . Serological reactivity of blood donors infected with three different types of hepatitis C virus. (Letter) Lancet 1991; 338: 1391.

Machida A. , Ohnuma H. , Tsuda F. . Two distinct subtypes of hepatitis C viruses defined by antibodies directed to the putative core protein. Hepatology 1992; 16: 886–91.

Stuyver L. , van Arnhem W. , Wyseur A. , DeLeys R. , Maertens G. . Analysis of the putative E1 envelope and NS4 epitope regions of the HCV type 3. Bioch Bioph Res Comm 1993; 192: 635–41.

Simmonds P. , Rose K.A. , Graham S. . Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2 and 3. J Clin Microbiol 1993; 31: 1493–503.

Tsukiyama-Kohara K. , Yamaguchi K. , Maki N. . Antigenecities of group I and II hepatitis C virus polypeptides-molecular basis of diagnosis. Virology 1993; 192: 430–7.

Maertens G. , Ducatteeuw A. , Vandenponseele P. . Type 2, 3 and 4 hepatitis C sera show a weak or absent reactivity towards recombinant type E1 protein. International symposium on Viral Hepatitis and Liver Disease, Tokyo, Abstract 1993; 322.

Chayama K. , Tsubota A. , Arase Y. . Genotyping subtyping of hepatitis C virus. J Gastr Hepatol 1993; 8: 150–6.

Kleter G.R.M. , van Doom L.J. , Browwer J.T. . At least four genotypes of HCV in the Netherlands. J Clin Microbiol 1994; 32: 306–10.

Cha Ta , Beall E. , Irvine B. . At least five related, but distinct, hepatitis C viral genotypes exixt. Proceedings of the National Academy of Sciences of the USA 1990; 87: 8898–902.

Nakao T. , Enomoto N. , Takada N. . Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 1991; 72 2105–12.

Enomoto N. , Takada A. , Nakao T. . There are two major types of hepatitis C virus In Japan. Bioch Biophis Res Comm 1990; 170: 1021–5.

Takada N. , Takase S. , Takada A. , Date T. . Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993; 17: 277–83.

Stuyver L. , Rossau R. , Wyseaur A. . Typing of HCV isolates and characterization of new (sub)types using a line probe assay. J Gen Virol 1993; 74: 1093–102.

Okamoto H. , Kurai K. , Okada S.I. . Full-length sequence of a hepatitis C virus having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992; 188: 331–41.

Pistello M. , Maggi F. , Vatteoni L. . Prevalence of HCV genotypes in Italy. J Clin Microbiol 1994; 32: 232–4.

Ravaggi A. , Zonaro A. , Marin M.G. . Distribution of viral genotypes in Italy determined by HCV typing by DNA immunoassay. J Clin Microbiol 1994; 32: 280–4.

Jeffers L.J. , Perez G.O. , de Medina M.D. . Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990; 38: 320–2.

Zeldis J.B. , Depner T.A. , Kuramoto I.K. , Gish R.G. , Holland P.V. . The prevalence of hepatitis C virus antibodies among haemodialysis patients. Ann Intern Med 1990; 112: 958–60.

Gilli P. , Moretti M. , Soffritti S. . Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Org 1990; 13: 737–41.

Hayashi J. , Nakashima K. , Kaijiyama W. , Noguchi A. . Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 1991; 134: 651–7.

Kallinowski B. , Theilmann L. , Gmelin K. . Prevalence of antibodies to hepatitis C virus in haemodialysis patients. Nephron 1991; 59: 236–8.

Dentico P. , Buongiomo R. , Volpe A. . Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors. Clin Nephrol 1992; 38: 49–52.

Fabrizi F. , Di Filippo S. , Erba G. , Locatelli F. . Hepatitis C virus infection and hepatic function in chronic haemodialysis patients. (Letter) Nephron 1992; 61: 119.

Conway M. , Caterall A.P. , Brown A. , Tibbs C. . Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 1992; 7: 1226–9.

Mondelli M.U. , Cristina G. , Piazza V. . High prevalence of antibodies to hepatitis C virus in hemodialysis units units using a second-generation assay. Nephron 1992; 61: 350–1.

Hardy N.M. , Sandroni S. , Danielson S. , Wilson W.J. . Antibody to hepatitis C virus increases with time on dialysis. Clin Nephrol 1992; 38: 44–8.

Vasile A. , Allegra V. , Canciani D. . Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies. Nephron 1992; 61: 318–9.

Oguchi H. , Miyasaka M. , Tokunaga S. , Hora K. . Hepatitis C virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephron 1992; 38: 36–43.

Fabrizi F. , Raffaele L. , Bacchini G. . Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays. Nephrol Dial Transplant 1993; 8: 744–7.

Knudsen F. , Wantzin P. , Rasmussen K. . Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993; 43: 1535–56.

Carrera F. , Silva J.G. , Oliveira C. . Persistence of antibodies to hepatitis C virus in a chronic haemodialysis population. Nephron 1994; 68: 38–40.

Fabrizi F. , Lunghi G. , Erba G. , Raffaele L. , Pagano A. , Locatelli F. . Prevalence of anti-HCV antibodies among haemodialysis patients: a study with third-generation screening and confirmatory assays. (Submitted to Am J Kidney Dis).

Chan T.M. , Lok A.S.F. , Cheng I.K.P. . Hepatitis C in renal transplant recipients. Transplantation 1991; 52: 810–3.

Ponz E. , Campistol J.M. , Bruguera M. . Hepatitis C virus infection among kidney transplant recipients. Kidney Int 1991; 40: 748–51.

Fabrizi F. , Maraii P. , Erba G. , Locatelli F. . Hepatitis C virus infection in kidney graft recipients. (Letter) Nephrol Dial Transplant 1992; 7: 274.

Marcen R. , Pascual J. , Orofino L. . Hepatitis C virus infection in kidney transplant patients. Transplant Proc 1992; 24: 87–8.

Fabrizi F. , Marai P. , Bacchini G. , Locatelli F. . Hepatitis C virus infection in kidney graft recipients: a study with second-generation assays. (Letter) Nephrol Dial Transplant 1992; 7: 1164–5.

Lau Y.N.J. , Davis G.L. , Brunson M.E. . Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993; 18: 1027–31.

Roth D. , Zucker K. , Cirocco R. , DeMattos A. , Burke . The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238–44.

Goffin E. , Pirson Y. , Cornu C. , Geubel A. . Outcome of HCV infection after renal transplantation. Kidney Int 1994; 45: 551–5.

McCruden E.A.B. , Welch S. , Batchelor B. . Hepatitis C virus infection detected by antibody tests and the polymerase chain reaction as a cause of liver dysfunction in renal transplant recipients. J Med Virol 1994; 42: 158–63.

Chan T.M. , Lok A.S.F. , Cheng I.K.P. . Hepatitis C infection among dialysis patients: a comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991; 6: 944–7.

Perez-Fontan M. , Moncalian J. , Rodriguez-Carmona A. . Prevalence of anti hepatitis C antibodies in patients treated with continuous ambulatory peritoneal dialysis and hemodialysis. Nephron 1991; 58: 381–2.

Ng Y.Y. , Lee S.D. , Wa C.S. . Antibodies to hepatitis C virus in uremic patients on continuous ambulatory peritoneal dialysis. J Med Virol 1991; 35: 263–6.

Selgas R. , Martinez-Zapico R. , Bajo M.A. . Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Peritoneal Dial Int 1992; 12: 28–30.

Huagg C.C. , Wu M.S. , Lin D.Y. , Liaw Y.F. . The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory dialysis. Peritoneal Dial Int 1992; 12: 31–3.

Gladziwa U. , Schlipkoter V. , Lorbeer B. . Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis: a multicenter study. Clin Nephrol 1993; 40: 46–52.

Fabrizi F. , Marai P. , Bigi M.C. , Locatelli F. . Unpublished data.

Calabrese G. , Vagelli G. , Guaschino R. . Transmission of anti-HCV within the household of haemodialysis patients. Lancet 1991; 338: 1466.

Niu M.T. , Alter M.J. , Kristensen C. . Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody for hepatitis C virus. Am J Kidney Dis 1992; 19: 345–52.

Jadoul , Cornu C. , Van Ypersele de Strihou C. . the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconverson in haemodialysis: a prospective study. Kidney Int 1993; 44: 1322–6.

Garcia-Valdecasas J. , Bernal N.C. , Cerezo S. , Garcia F. , Pereira B.J.G. . Strategies to reduce the transmission of HCV infection in hemodialysis units. (Abstract) J Am Soc Nephrol 1993; 4: 347.

Fabrizi F. , Lunghi G. , Pagano A. , Locatelli F. . Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study. Nephrol Dial Transplant 1994; 9: 1611–5.

Fabrizi F. , Marcelli D. , Conte F. , Locatelli F. . Incidenza di sieroconversione per anticorpi anti-HCV in pazienti in terapia sostitutiva renale cronica: dati dal Registro Lombardo Dialisi e Trapianto. In: Cannella G. , Tizianello A. , eds. XXXVI Italian Congress of Nephrology. Abstracts. Genova, Italy, May 17–20 1995 (in press).

Mitwally A. , Al-Mohaya S. , Wakeel J. . Hepatitis C in chronic renal failure patients. Am J Nephrol 1993; 12: 288–91.

Gerakis A. , Kapasouri E. , Hadjimitrou G. , Billis A. . High prevalence of anti-HCV among renal patients with or without renal failure. (Letter) Nephrol Dial Transplant 1993; 8: 1307–8.

Fabrizi F. , Marcelli D. , Erba G. , Locatelli G. . Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Nephrol Dial Transplant 1994; 9: 780–4.

Chiaramonte M. , Stroffolini T. , Caporaso N. . Hepatitis C virus infection in Italy: a multicentric seroepidemiological study. It J Gastroenterol 1991; 23: 555–8.

Albano A. , Pianetti A. , Biffi M.R. . Prevalence of anti-HCV in subjects of various age groups. Eur J Epidemiol 1992; 8: 309–11.

Caramelo C. , Ortiz A. , Aguilera B. . Liver disease patterns in haemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993; 22: 822–8.

Alfuray O. , Sobh M. , Buali A.R. . Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathological study. Nephrol Dial Transplant 1992; 7: 327–32.

Fabrizi F. , Lunghi G. , Guarnori I. , Pagano A. , Locatelli F. . Virological characteristics of hepatitis C virus infection in chronic haemodialysis patients: a cross-sectional study. Clin Nephrol 1995 (accepted for publication).

Pol S. , Romeo R. , Zins B. . Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097–100.

Picciotto A. , Varagona G. , Guerreri G. . Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients. Nephrol Dial Transplant 1993; 8: 1115–7.

Sheu J.C. , Lee S.H. , Wang J.T. , Shih L.N. . Prevalence of anti-HCV and HCV viraemia in haemodialysis units in Taiwan. J Med Virol 1992; 37: 108–12.

Chan T.M. , Lok A.S.F. , Cheng I.K.P. , Chan R.T. . Prevalence of hepatitis C virus infection in haemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1992; 15: 19–25.

Dussol B. , Chicheportiche C. , Cantaloube J.F. , Roubicek C. . Detection of hepatitis C infection by polymerase chain reaction among haemodialysis patients. Am J Kidney Dis 1993; 22: 574–80.

Nordenfelt E. , Lofgren B. , Widell A. . Hepatitis C virus infection in haemodialysis patients in southern Sweden: epidemiological, clinical, and diagnostic aspects. J Med Virol 1993; 40: 266–70.

Fabrizi F. , Lunghi G. , Marai P. , Guarnori I. , Raffaele L. , Locatelli F. . Virological and histological features of HCV infection in kidney graft recipients (submitted to Nephrol Dial Transplant).

Haddad J. , Deny P. , Munz-Gotheil C. . Lymphocytic sialoadenitis of Sjiogren's syndrome associated with chronic hepatitis virus liver disease. Lancet 1992; 339: 321–3.

Herrero C. , Vicente A. , Bruguera M. . Is hepatitis C virus infection a trigger of porphyria curanea tarda? Lancet 1993; 341: 788–9.

Pateron D. , Hartmann D.J. , Duclos-Vallee J.C. . Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992; 16: 244–5.

Cacoub P. , Lunel-Fabian F. , Huong Du L.T. . Polyarteritis nodosa and hepatitis C virus infection. Ann Int Med 1992; 116: 605–6.

Quint L. , Deny P. , Guillevin L. . Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol 1991; 9: 253–7.

Sawada T. , Hirohata S. , Inoue T. . Development of rheumatoid arthritis after hepatitis C virus infection. Arth Rheum 1991; 34: 1620–3.

Ferri C. , Greco F. , Longobardo G. . Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1606–10.

Misiani R. , Bellativa P. , Fenili D. . Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Int Med 1992; 117: 573–7.

Levey J.M. , Bjornsson B. , Banner B. . Mixed cryoglobulinemia in chronic hepatitis C Infection. Medicine 1994; 73: 53–67.

Fabrizi F. , Conte F. , Marcelli D. , Locatelli F. . Anti-HCV antibodies in patients on chronic renal replacement therapy: a report from the Lombardy Regional Dialysis and Transplant Registry. In: Stummvoll H.K. , ed. XXXIst Congress of the EDTA-ERA. Abstracts. Vienna, Austria, July 3–6 1994; 179.

Doutrelepont J.M. , Adler M. , Willems M. . Hepatitis C infection and membranoproliferative glomerulonephritis. (Letter) 1993; 341: 416.

Albarracin C. , Gomez Campdera F.J. , Lopez Gomez J.M. . Membranoproliferative glomerulonephritis and hepatitis C virus infection. (Letter) Nephron 1994; 67: 250.

Gonzalo A. , Barcena R. , Mampaso F. . Membranoproliferative glomerulonephritis and hepatitis C virus infection. (Letter) 1993; 63: 475–6.

Harlé J.R. , Disdier P. , Dussol B. . Membranoproliferative glomerulonephritis and hepatitis C infection. (Letter) Lancet 1993; 341: 904.

Burstein D.M. , Rodby R.A. . Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 1993; 4: 1288–93.

Pasquariello A. , Ferri C. , Moriconi L. . Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus. Am J Nephrol 1993; 13: 300–4.

Johnson R.J. , Gretch D.R. , Yamabe H. , Hart J. . Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465–70.

Davda R. , Peterson J. , Weiner R. . Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 1993; 22: 452–5.

Yamabe H. , Fukushi K. , Ohsawa H. , Miyata M. . Hepatitis C virus (HCV) infection may be an important cause of membranoproliferative glomerulonephritis in Japan. (Abstract) J Am Soc Nephrol 1993; 4: 291.

Rollino C. , Roccatello D. , Giachino O. , Basolo B. . Hepatitis C virus infection and membranous glomerulonephritis. (Letter) Nephron 1991; 59: 319–20.

Horikoshi S. , Okada T. , Shirato I. , Inokichi S. . Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis. (Letter) Nephron 1993; 64: 462–4.

Fabrizi F. , Pozzi C. , Fogazzi G. , Farina M. , Locatelli F. . Anticorpi anti-HCV in pazienti affetti da glomerulonefrite primitiva e secondaria biopticamente accertata. In: Schena F.P. , ed. XXXV Italian Congress of Nephrology. Abstracts. Bari, Italy, May 18–21 1994; 68.

Rostoker G. , Deforges L. , Ben Maadi A. . Low prevalence of hepatitis C virus antibodies among adult patients with primary glomerulonephritis in France. (Letter) Nephron 1993; 63: 367.

Strom E.H. , Durmuller U. , Gudat F. , Mihatsch M.J. . Hepatitis C virus plays no role in the pathogenesis of immunoglobulin A nephropathy in liver cirrosis. (Letter) 1994; 67: 370.

Theilmann L. , Gmelin K. , Kallinovski B. . Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis. (Letter) Nephron 1991; 57: 482.

Cottiero R. , Westrick E. , Weinberg M. . Membranoproliferative glomerulonephritis associated with chronic hematitis C virus infection. (Abstract) J Am Soc Nephrol 1992; 3: 309A.

Johnson R.J. , Gretch D.R. , Couser W.G. , Alpers C.E. . Hepatitis C virus-associated glomerulonephritis. Effect of interferon therapy. Kidney Int 1994; 1700–4.

Misiani R. , Bellavita P. , Fenili D. . Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751–6.

Yamabe H. , Johnson R.J. , Gretch D.R. , Osawa H. . Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-alpha. Am J Kidney Dis 1995; 25: 67–9.

Johnson J.R. , Gretch D.R. , Yamabe H. , Couser W.G. , Willson R. . Interferon-alpha in the treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection: do we have enough data or are we still in the learning stage? J Nephrol 1994; 7: 336–9.